MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, ...

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...

Wall Street strategists are largely leaning positive on stocks, and that may mean it’s time to go the other way.

The average of price targets set by Wall Street analysts indicates a potential upside of 33.7% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, ...

The Indicator from Planet Money A little show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening today. It's a quick hit of insight into ...

That versatile indicator was the Starrett W4900 Touch Screen Indicator from The L.S. STARRETT CO., manufacturer of precision measuring tools and gages, and metrology systems. James Clinton, inside ...

Algorand (ALGO) is consolidating in a symmetrical triangle, with rising MVRV scores, institutional support, and low ...

Together, recent advances in modern microscopy and improved genetically encoded calcium indicators (GECIs) have revolutionized systems neuroscience by allowing chronic simultaneous optical recording ...